Biodel Inc. to Present at Natixis Bleichroeder Hidden Gems Conference on Octob... ( DANBURY Conn. Oct. 4 /- Biodel In...)

Biodel Inc. to Present at Natixis Bleichroeder Hidden Gems Conference on October 8, 2007

Date:10/4/2007

DANBURY, Conn., Oct. 4 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the Natixis Bleichroeder Hidden Gems Conference in New York, NY on October 8th at 10:00 AM ET.

Interested parties may access a link to a live audio webcast of the presentation in the investor relations section of Biodel's website at http://www.biodel.com. A replay of the presentation will be available for 14 days.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed by using VIAdel(TM) technology, which reformulates existing FDA- approved peptide drugs. The Company's lead product candidate, VIAject(TM), is a rapid-acting injectable meal-time insulin in development for use by patients with Type 1 or Type 2 diabetes. VIAject(TM) is currently being tested in two pivotal Phase III clinical trials. Biodel's pipeline also includes VIAtab(TM), a sublingual tablet formulation of insulin in Phase I clinical trials and two osteoporosis product candidates in pre-clinical studies. For further information regarding Biodel, please visit the Company's website.

Safe Harbor

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other then statements of historical facts, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management are forward- looking statements. The words "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would" and similar expr
'/>"/>

SOURCE Biodel Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:

(Date:11/6/2009)...alif., Nov. 6 ,, 3...fer of Qutenza(TM) E.U. Marketing Authorization to...ogress in commercial readiness activities Expande...ctor, Marketing; and Director, Commercial Operatio...ctor and Audit Committee chairman , Upcomin...

(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Pers...s set to take place on February 22-24, 2010 in Phi...onference we will highlight key issues in forming ... their experiences. , Min...a for Arrowhead’s 2010 Personalized Medicin...

(Date:11/5/2009)...N.J., Nov. 5 DSM Pharmaceutical Pr...uring alliance with Galenix, Saint Jean D,Illac, F...scale manufacturing partner for Galenix commercial... will collaborate on business development opportun...ies, based on the strength of Galenix in drug prod...

(Date:11/5/2009)... Nov. 5 Transgenomic, In...ncial results for the quarter ended September 30, ...d in the tables that follow. ,, Third Quarter ...6,000 or $0.01 per share for the third quarter of ...1 per share for the third quarter of 2008. ,, ...

[0] NeurogesX Reports Third Quarter 2009 Results [0] Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference [0] DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix [0] Transgenomic, Inc. Reports Third Quarter 2009 Results

...Pa., May 18 ViroPharma Incorporated (Nasdaq: VP...ional Organization for Rare Disorders (NORD) Annua...terase inhibitor (human)) to market for a rare and...E). , , HAE is a rare, severely debilitating, lif...ncy of C1 inhibitor, a human plasma protein. Patie...

...gazine Pays Tribute to America,s Top Research Scie...air of Prana,s Biotechnology Research & Develo...May 18 Dr. Rudy Tanzi, Prana Biotechnology,s (Nas...tor of the Genetics and Aging Research Unit at the...ses , will be featured in a six-page photo spread...

... Will be Reported from Phase 2 Studies Evaluating ...tal Cancer and Gastrointestinal Stromal Tumors (GI...ls, Inc. (Nasdaq: KERX ) today announced that fo...,s Akt-inhibitor for cancer, were accepted for pre...he 45th Annual Meeting of the American Society of ...

Other Biology Technology:ViroPharma Incorporated Honored by the National Organization for Rare Disorders 2 ViroPharma Incorporated Honored by the National Organization for Rare Disorders 3 ViroPharma Incorporated Honored by the National Organization for Rare Disorders 4 ViroPharma Incorporated Honored by the National Organization for Rare Disorders 5 ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot 2 ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot 3 Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 2 Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 3 Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 4

ViroPharma Incorporated Honored by the National Organization for Rare Disorders ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology

(Date:11/4/2009)...- Lowly bacteria, it turns out, hold the power to ... around the world clean up toxic waste on test sit...y RDX, were invented back in World War II and have...se high-energy compounds are often used to propel ...f TNT. , But with increased knowledge of their...

(Date:11/4/2009)....J., Oct. 20 Quest Diagn...ding provider of diagnostic testing, information a...ended September 30, 2009, income from continuing o...ed share, from $160 million, or $0.81 per diluted ...rd quarter results were reduced by a $0.03 per sha...

(Date:11/4/2009)...Calif., Oct. 23 GenVault Corporati...nagement for genomic discovery, medicine and ident...., GenVault,s President and CEO, will be presentin...n October 26th and 27th in La Jolla, CA. ,, Dur...verview of the company together with recent custom...

[0] Genomic research will enable greener cleanup of military explosive test sites [0] Quest Diagnostics Reports Strong Performance in Third Quarter 2009 [0] GenVault Corporation to Present at the 2009 BIOCOM Investor Conference

...ve hair-like protrusions with a sticky protein on ...ed, bungee cord-like structure of the protrusions ...gh fluid flow inside the body, researchers report ...hers at the University of Washington in Seattle an... the bacterium E. coli attaches to mucous membrane...

...h shows that a chemical compound found in many air...ther deodorizing products, may be harmful to the l...titute of Environmental Health Sciences (NIEHS), a...that exposure to a volatile organic compound (VOC)...odest reductions in lung function. , "Even a small...

... microorganisms manage to exist and even thrive in...ot springs? A team of scientists from the Weizmann...f. Avigdor Scherz, has found that a switch in just...can make a difference between functioning best at ...in extreme heat. The results of their research, wh...

Other Biology News:Tiny shock absorbers help bacteria stick around inside the body 2 Chemical in many air fresheners may reduce lung function 2 Chemical in many air fresheners may reduce lung function 3 Bacteria beat the heat 2

Tiny shock absorbers help bacteria stick around inside the body Chemical in many air fresheners may reduce lung function Bacteria beat the heat

...nal [6331] to Salmonella typhimurium The genus Sa...eae. The genus is composed of Gram-negative bacill...Salmonellae possess 3 major antigens; the "H" or f... antigen (part of the LPS moiety) and the "Vi" or ...

...W4 liquid handling system from Molecular Devices p...l in one instrument. The system handles a variety ...6-, 384- and 1536-welland is the first to handle 1...optimized to dispense from four different channels...

...sodium pyruvate, 50 mg/L streptomycin sulfate, 100...lcium chloride, and magnesium chloride. The use of...is generally attributed to early workers in the fi...f inorganic salts designed to maintain contractili...

Horizontal Laminar Flow Work Station from Terra Universal, Inc.

Biology Products:

Mouse Anti-Salmonella typhimurium Monoclonal Antibody, Unconjugated, Clone 6331 from GeneTex AquaMax DW4 from Molecular Devices Dulbecco's Phosphate Buffered Saline (DPBS) from Sigma-Aldrich Horizontal Laminar Flow Work Station from Terra Universal, Inc.

Biodel Inc. to Present at Natixis Bleichroeder Hidden Gems Conference on Octob...( DANBURY Conn. Oct. 4 /- Biodel In...)